logo
Harken Sweets Wins NIQ's Third Annual Pitch Slam at Consumer 360 ® Event

Harken Sweets Wins NIQ's Third Annual Pitch Slam at Consumer 360 ® Event

Business Wire04-06-2025
CHICAGO--(BUSINESS WIRE)--NielsenIQ (NIQ) has announced the winner of its third annual Pitch Slam competition during NIQ's Consumer 360 ® (C360 ®) event. The five finalists—Daybird, Evergreen, Harken Sweets, Mingle Beverage Company, and Pricklee—went head-to-head competing for a grand prize valued at over $700,000 in cash and in-kind services, with Harken Sweets winning the hearts of the judges and audience members.
Harken Sweets was founded by Harvard Business School graduate Katie Lefkowitz in 2022, who—after a personal health scare—was determined to reinvent candy as we know it. With no added sugar, plant-based ingredients, and prebiotic fiber, Harken Sweets delivers classic chocolate joy that's gut-friendly, dairy-free, and loves you back.
In winning the Pitch Slam competition, Harken Sweets will now have exclusive access to NIQ's data experts to help build their brand through the lens of best-in-class data and analytics, in addition to the cash prize.
'We are thrilled to recognize the innovative spirit and exceptional talent demonstrated by this year's Pitch Slam winner. Their groundbreaking ideas and dedication to excellence embody the very essence of what this competition stands for,' said NIQ's Andrew Criezis, President of Omni-commerce. 'At NIQ, we believe in fostering creativity and supporting visionary entrepreneurs who are shaping the future. Congratulations to Katie and Harken Sweets for their remarkable achievement and for inspiring us all with their ingenuity and passion.'
As one of the largest CPG pitch slams of the year for founding entrepreneurs, this C360 ® mainstage event provides a rare opportunity for emerging CPG brand makers to pitch their greatest innovations and transformative products.
'We are incredibly honored to have won NIQ's Pitch Slam competition. This recognition is a testament to our mission of reinventing candy with health and joy at its core,' said Katie Lefkowitz, founder of Harken Sweets. 'We are excited to leverage NIQ's expertise to further our vision and bring Harken Sweets to even more people who are looking for a candy bar that loves them back.'
For further information, including eligibility details and the application process for the NIQ Pitch Slam competition, please visit the NIQ website at niq.com/pitchslam.
About NIQ
NielsenIQ (NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together two industry leaders with unparalleled global reach. Our global reach spans over 90 countries covering approximately 85% of the world's population and more than $7.2 trillion in global consumer spend. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View ™.
For more information, please visit www.niq.com
About Harken Sweets
Harken Sweets reimagines joy-inspiring, iconic treats, infusing them with superfood fruits that nourish and satiate. Harken products use the date fruit as its hero ingredient, resulting in nutrient-rich products that are lower in calories, sugar, and fat than traditional offerings. By innovating a new market category, Harken is reimagining indulgence so that Americans finally can LOVE CANDY AGAIN.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SharkNinja rolls into Hollywood spotlight in latest Brad Pitt movie
SharkNinja rolls into Hollywood spotlight in latest Brad Pitt movie

Boston Globe

time32 minutes ago

  • Boston Globe

SharkNinja rolls into Hollywood spotlight in latest Brad Pitt movie

SharkNinja hosted a 'consumer activation' in New York's Times Square ahead of the city's official premiere, with product demo stations, where passersby could try a Ninja Slushi or a Shark FlexStyle hair styler. Advertisement SharkNinja's Limited-Edition APXGP Performance Collection, as featured in Apple Original Films' F1® The Movie The company hopes to show its ethos around 'design, speed and performance' is reflected in the movie's storyline. For example, chief executive Mark Barrocas said that like 'the characters in the film, we're always pushing to do more, do better, and defy expectations.' Advertisement Spokesman Brandon Hart declined to say how much the company is spending on the movie appearances. Also unclear: how that amount compares with what the company would have to spend to sponsor a real F1 team. This is an installment of our weekly Bold Types column about the movers and shakers on Boston's business scene. Jon Chesto can be reached at

India's services sector growth hits 10-month high in June as demand strengthens
India's services sector growth hits 10-month high in June as demand strengthens

Business Upturn

time4 hours ago

  • Business Upturn

India's services sector growth hits 10-month high in June as demand strengthens

By Aditya Bhagchandani Published on July 3, 2025, 10:49 IST India's services sector saw robust expansion in June 2025, with business activity rising at its fastest pace in 10 months, driven by strong domestic demand and improving export orders. The HSBC India Services PMI® Business Activity Index climbed to 60.4, up from 58.8 in May, according to the latest survey by S&P Global. A reading above 50 indicates expansion. Service providers reported the sharpest rise in new orders since August 2024, supported by solid growth in both domestic and international markets, particularly from Asia, the Middle East, and the US. Notably, the pace of export growth was among the strongest since records began, though slightly lower than in previous months. Price pressures continued to ease, with input and output price inflation softening to a 10-month low. Employment in the sector grew for the 37th consecutive month, although the pace of job creation moderated from May's record levels. Finance & Insurance led sectoral growth in June, while Real Estate & Business Services lagged behind. On the outlook, service providers remained optimistic about future growth, though overall confidence dipped slightly compared to previous months. Key highlights: Business Activity Index rose to 60.4 in June (58.8 in May) New orders increased at the fastest rate in nearly a year Export orders strong, despite a slight slowdown from May Input cost inflation at a 10-month low; firms maintained pricing power Job creation continues, though at a slower pace Finance & Insurance sector remains the top performer According to Pranjul Bhandari, Chief India Economist at HSBC: 'The Services PMI business activity index was up to a ten-month high, led by a sharp rise in new domestic orders. Margins improved as the rise in input costs was below that seen for output charges.' The data reflects broad-based resilience in India's private sector, with the HSBC India Composite PMI Output Index — combining manufacturing and services — also reaching a 14-month high of 61.0 in June. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

Transition of Promotional Activities for Allergen Immunotherapy Drug Actair® in Japan
Transition of Promotional Activities for Allergen Immunotherapy Drug Actair® in Japan

Business Wire

time5 hours ago

  • Business Wire

Transition of Promotional Activities for Allergen Immunotherapy Drug Actair® in Japan

BAAR, Switzerland & OSAKA, Japan & TOKYO--(BUSINESS WIRE)--Stallergenes Greer, Shionogi & Co., Ltd. ('Shionogi') and CEOLIA Pharma Co. Ltd ('CEOLIA') today announced the transition of promotional activities for Actair® in Japan. Actair® is Stallergenes Greer's sublingual immunotherapy tablet for the treatment of patients suffering from house dust mite induced allergic rhinitis. After ending the license agreement established in 2010 with Shionogi, which had been responsible for developing, registering, and commercialising Actair® in Japan, Stallergenes Greer has appointed CEOLIA as its new promotional partner in the country starting July 3. To ensure the continuity of both patient care and support for healthcare professionals, Shionogi will continue during a transition period to serve as the Marketing Authorisation Holder (MAH) in Japan and remain responsible for the importation, manufacturing and distribution of Actair®. Shionogi will also provide active support to CEOLIA by transferring knowledge and offering operational assistance. Stallergenes Greer acknowledges Shionogi's contribution and sustained commitment to improving allergy care in Japan. The company welcomes CEOLIA as a trusted new partner and looks forward to working closely together to further advance access to allergen immunotherapy treatments and continue to improve the quality of life of patients with respiratory allergies. ABOUT STALLERGENES GREER Headquartered in Baar (Switzerland), Stallergenes Greer is a global healthcare company specialising in the diagnosis and treatment of allergies through the development and commercialisation of allergen immunotherapy products and services. Supported by more than 100 years of expertise and innovation, our products are available for patients in over 40 countries. For more information, visit ABOUT SHIONOGI & Co. Ltd Shionogi has identified 'Contributing to a Healthy and Prosperous Life' as one of its key material issues. The group is committed to building a society where everyone can live vibrantly and true to themselves. With a continued focus on areas of high unmet medical needs, Shionogi strives to deliver innovative treatments that improve the quality of life (QOL) for patients and their families. For more information, visit ABOUT CEOLIA CEOLIA, founded in 2010, is a pharmaceutical company dedicated to serving all healthcare needs in the otolaryngology (ENT) field. With a mission and philosophy to serve and contribute to people's health and happiness, we develop and manufacture and market ethical drugs, medical devices, and diagnostic reagents in the ENT field. For more information, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store